Inventor
ZHAO JINGJING
US37 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO JINGJING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
14 patentsUS9512124B2Dec 6, 2016
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC32 citations96
US9737541B2Aug 22, 2017
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC12 citations91
US9771371B2Sep 26, 2017
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
SIGNAL PHARM LLC4 citations83
US8907087B2Dec 9, 2014
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
SIGNAL PHARM LLC4 citations83
US9079900B2Jul 14, 2015
Methods of synthesis and purification of heteroaryl compounds
SIGNAL PHARM LLC5 citations82
US10940152B2Mar 9, 2021
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC1 citations72
US10646493B2May 12, 2020
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC1 citations72
US10398700B2Sep 3, 2019
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations72
US10167290B2Jan 1, 2019
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
SIGNAL PHARM LLC1 citations72
US10149849B2Dec 11, 2018
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations72
US11292796B2Apr 5, 2022
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
SIGNAL PHARM LLC0 citations62
US11590139B2Feb 28, 2023
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC0 citations61
US10683298B2Jun 16, 2020
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
SIGNAL PHARM LLC0 citations51
US9193692B2Nov 24, 2015
Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
SIGNAL PHARM LLC0 citations51
PERRIN-NINKOVIC SOPHIE
3 patentsUS8492381B2Jul 23, 2013
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
PERRIN-NINKOVIC SOPHIE44 citations95
US8110578B2Feb 7, 2012
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
PERRIN-NINKOVIC SOPHIE67 citations95
US8507492B2Aug 13, 2013
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
PERRIN-NINKOVIC SOPHIE22 citations90
HUAWEI TECH CO LTD
3 patentsUS12395428B2Aug 19, 2025
Route recursion control method, device, and system
HUAWEI TECH CO LTD0 citations62
US11888722B2Jan 30, 2024
Route advertisement method, device, and system
HUAWEI TECH CO LTD1 citations62
US11652737B2May 16, 2023
Route recursion control method, device, and system
HUAWEI TECH CO LTD1 citations62
FCA US LLC
3 patentsUS12592440B2Mar 31, 2026
Battery pack casing having crush resistance and thermal insulation for electrified vehicle
FCA US LLC0 citations57
US12592515B2Mar 31, 2026
High voltage interlock bypass connector
FCA US LLC0 citations44
US12597749B2Apr 7, 2026
Replaceable low voltage connector adapter with integrated fuse design
FCA US LLC0 citations41